Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  WellPoint Inc    WLP

WELLPOINT INC (WLP)
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

WellPoint, Inc. : WellPoint Sees CEO Decision Soon, Could Top 2012 View

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/08/2013 | 09:19pm CEST

--WellPoint expects decision on new CEO sometime in the first quarter

--Health insurer says 2012 earnings could be slightly above prior expectations

--Company expects to participate in exchanges in all states where it operates

(Adds comments from J.P. Morgan conference and more background throughout.)

 
   By Jon Kamp 
 

SAN FRANCISCO--Health insurer WellPoint Inc. (WLP) said Tuesday it is getting close to selecting a new chief executive and 2012 earnings may be near the high end or slightly above the company's prior expectations.

The Indianapolis-based company just wrapped up a challenging year. Former Chief Executive Angela Braly stepped down abruptly in August, a month after a rocky second-quarter report agitated investors who were already miffed about the company's unsteady performance.

WellPoint General Counsel John Cannon took over as interim CEO but also said he didn't want the top job on a permanent basis, and the health insurer's board has been searching for Ms. Braly's successor.

Speaking at the J.P. Morgan health-care conference Tuesday, Mr. Cannon said the insurance company expects to decide on a permanent CEO this quarter, "hopefully sooner rather than later."

The company gave its preliminary view of results for the just-concluded year in a regulatory filing ahead of Mr. Cannon's presentation. While WellPoint was cautious on its forecast in November--holding its adjusted earnings view of $7.30 to $7.40 a share in check despite posting a better-than-expected third quarter--the company said Tuesday that it may top that target.

Chief Financial Officer Wayne DeVeydt said in November that WellPoint was taking a conservative view amid investors' interest in seeing less volatility. But BMO Capital Markets noted Tuesday that Wall Street estimates have been drifting higher anyway.

The adjusted forecast excludes items like a tax adjustment and closing costs related to the recent purchase of Medicaid insurer Amerigroup.

Meantime, WellPoint also advised that 2013 is shaping up to be an investment year, with plans to pump $200 million to $300 million before taxes to invest in growth initiatives, such as the planned health-law exchanges and the burgeoning market for dual Medicare/Medicaid patients.

The company on Tuesday said it expects adjusted per-share earnings to "grow moderately" this year because of a lower share count amid relatively stable net income. The 2013 view includes Amerigroup integration costs.

The company closed on its $4.46 billion Amerigroup purchase two weeks ago. The deal created the largest Medicaid insurer while also lessening WellPoint's tilt toward individual and small-group commercial health insurance, which are markets expected to see the biggest impact from the U.S. health-care overhaul law.

Big features of the health law, like state-based exchanges where individuals can shop for coverage, are supposed to start up next year. Mr. Cannon said WellPoint expects to participate in exchanges in all of the states where it operates. He also said WellPoint is well-positioned for the coming changes.

"Many people fear health-care reform, and I may be smoking something, but I'm excited about it," Mr. Cannon said. "The government wants to make it work, and they need us to make it work."

--Joseph Walker and Saabira Chaudhuri contributed to this article.

Write to Jon Kamp at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WELLPOINT INC
05/18EXPRESS SCRIPTS : and Cigna were exploring deals with other companies before agr..
AQ
05/16ANTHEM, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, ..
AQ
05/14U.S. to consider expanding Medicare drug price negotiation
RE
05/11ANTHEM INC : Free Research Report as Anthem’s EPS Surged 34%
AC
05/11ANTHEM : lone ACA provider again Anthem is only insurer expecting to sell indivi..
AQ
05/10DIPLOMAT PHARMACY : Appoints Brian Griffin as Chief Executive Officer and Chairm..
AQ
05/10ANTHEM, INC. : Change in Directors or Principal Officers, Financial Statements a..
AQ
05/10ANTHEM : Chief Operating Officer Deepti Jain to Lead IngenioRx
BU
05/08ANTHEM : Area ACA insurer asking to raise rates
AQ
05/08ANTHEM : Seeks Rate Increases
AQ
More news
Financials ($)
Sales 2018 91 274 M
EBIT 2018 5 834 M
Net income 2018 3 751 M
Debt 2018 -
Yield 2018 1,29%
P/E ratio 2018 16,14
P/E ratio 2019 14,38
Capi. / Sales 2018 0,65x
Capi. / Sales 2019 0,62x
Capitalization 59 153 M
Chart WELLPOINT INC
Duration : Period :
WellPoint Inc Technical Analysis Chart | WLP | US94973V1070 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 284 $
Spread / Average Target 23%
EPS Revisions
Managers
NameTitle
Gail Koziara Boudreaux President, Chief Executive Officer & Director
Elizabeth E. Tallett Independent Chairman
John E. Gallina Chief Financial Officer & Executive Vice President
Craig E. Samitt Chief Clinical Officer & Executive Vice President
Ramiro G. Peru Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
WELLPOINT INC39.80%59 153
UNITEDHEALTH GROUP10.97%233 480
ANTHEM INC3.05%59 153
AETNA-3.17%57 907
CIGNA-11.91%43 447
HUMANA17.27%40 054